{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:01:17Z","timestamp":1784091677826,"version":"3.55.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alpha-1 antitrypsin deficiency (AATD) is characterized by low levels of circulating alpha-1 antitrypsin and an increased risk for emphysema, liver disease, and panniculitis. The reduced levels of alpha-1 antitrypsin in AATD predispose the lung to unopposed proteolytic activity, predominantly from neutrophil-derived proteases, chiefly neutrophil elastase. This leads to emphysema. The mechanisms subtending the liver disease are less well understood, but are probably due to a \u201cgain-of function\u201d inflammatory process in the liver, stoked by intracellular retention of aberrantly folded alpha-1 antitrypsin. The panniculitis associated with AATD is most likely due to unopposed proteolytic activity in the skin. Although AATD has been traditionally viewed as a condition arising from a protease\u2013antiprotease imbalance in the lung, it is increasingly recognized that AATD is an inflammatory disorder, both in the lung and in the extrapulmonary manifestations associated with the condition. This inflammation is predominantly neutrophil driven, and there are several alpha-1 antitrypsin\u2013related mechanisms involved in potentiating this neutrophilic response. The rationale for AAT augmentation therapy in AATD is classically based on restoring the antiprotease balance in the lung, but its beneficial effects may also be exerted systemically, further exposing the pathogenesis of AATD-related disease and indicating a potential usage for alpha-1 antitrypsin in other inflammatory conditions.<\/jats:p>","DOI":"10.1513\/annalsats.201509-634kv","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T13:23:11Z","timestamp":1472217791000},"page":"S297-S304","source":"Crossref","is-referenced-by-count":76,"title":["The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency"],"prefix":"10.1093","volume":"13","author":[{"given":"Cormac","family":"McCarthy","sequence":"first","affiliation":[{"name":"Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer P.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel G.","family":"McElvaney","sequence":"additional","affiliation":[{"name":"Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"2026020402541060100_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.rmed.2010.01.016","article-title":"Alpha-1 antitrypsin deficiency","volume":"104","author":"Kelly","year":"2010","journal-title":"Respir Med"},{"key":"2026020402541060100_bib2","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1016\/S0021-9258(18)81646-5","article-title":"Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion","volume":"264","author":"Curiel","year":"1989","journal-title":"J Biol Chem"},{"key":"2026020402541060100_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z alpha 1-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"key":"2026020402541060100_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1164\/rccm.201311-1984OC","article-title":"Clarification of the risk of chronic obstructive pulmonary disease in \u03b11-antitrypsin deficiency PiMZ heterozygotes","volume":"189","author":"Molloy","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402541060100_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9343(88)80066-4","article-title":"Molecular basis of alpha-1-antitrypsin deficiency","volume":"84","author":"Brantly","year":"1988","journal-title":"Am J Med"},{"key":"2026020402541060100_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0009-9260(82)80297-3","article-title":"Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association","volume":"33","author":"Gishen","year":"1982","journal-title":"Clin Radiol"},{"key":"2026020402541060100_bib7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/rccm.200406-761OC","article-title":"Pattern of emphysema distribution in \u03b11-antitrypsin deficiency influences lung function impairment","volume":"170","author":"Parr","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402541060100_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1172\/JCI115391","article-title":"Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency: spontaneous release of leukotriene B4 by alveolar macrophages","volume":"88","author":"Hubbard","year":"1991","journal-title":"J Clin Invest"},{"key":"2026020402541060100_bib9","doi-asserted-by":"crossref","first-page":"250S","DOI":"10.1378\/chest.117.5_suppl_1.250S","article-title":"Lung neutrophil burden correlates with increased pro-inflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency","volume":"117","author":"Rouhani","year":"2000","journal-title":"Chest"},{"key":"2026020402541060100_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.2005.043471","article-title":"Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects","volume":"61","author":"Malerba","year":"2006","journal-title":"Thorax"},{"key":"2026020402541060100_bib11","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1378\/chest.125.5.1952","article-title":"Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant","volume":"125","author":"Mulgrew","year":"2004","journal-title":"Chest"},{"key":"2026020402541060100_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(03)00482-4","article-title":"Neutrophil elastase up-regulates interleukin-8 via Toll-like receptor 4","volume":"544","author":"Devaney","year":"2003","journal-title":"FEBS Lett"},{"key":"2026020402541060100_bib13","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1172\/JCI41196","article-title":"\u03b1-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8","volume":"120","author":"Bergin","year":"2010","journal-title":"J Clin Invest"},{"key":"2026020402541060100_bib14","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.4049\/jimmunol.1500038","article-title":"The BLT1 inhibitory function of \u03b1-1 antitrypsin augmentation therapy disrupts leukotriene B4 neutrophil signaling","volume":"195","author":"O\u2019Dwyer","year":"2015","journal-title":"J Immunol"},{"key":"2026020402541060100_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.316188","article-title":"Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans","volume":"206","author":"Gadek","year":"1979","journal-title":"Science"},{"key":"2026020402541060100_bib16","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.79.6.2041","article-title":"Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity","volume":"79","author":"Carp","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020402541060100_bib17","doi-asserted-by":"crossref","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","article-title":"Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity","volume":"275","author":"Taggart","year":"2000","journal-title":"J Biol Chem"},{"key":"2026020402541060100_bib18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI113214","article-title":"Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase","volume":"80","author":"Ogushi","year":"1987","journal-title":"J Clin Invest"},{"key":"2026020402541060100_bib19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ajpath.2014.04.015","article-title":"Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema","volume":"184","author":"Guyot","year":"2014","journal-title":"Am J Pathol"},{"key":"2026020402541060100_bib20","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI114298","article-title":"Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis","volume":"84","author":"Berger","year":"1989","journal-title":"J Clin Invest"},{"key":"2026020402541060100_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1172\/JCI114699","article-title":"Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch","volume":"86","author":"Tosi","year":"1990","journal-title":"J Clin Invest"},{"key":"2026020402541060100_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm1690","article-title":"Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease","volume":"13","author":"Hartl","year":"2007","journal-title":"Nat Med"},{"key":"2026020402541060100_bib23","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4049\/jimmunol.1300711","article-title":"Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung","volume":"192","author":"Vega-Carrascal","year":"2014","journal-title":"J Immunol"},{"key":"2026020402541060100_bib24","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.4049\/jimmunol.1003187","article-title":"Dysregulation of TIM-3\u2013galectin-9 pathway in the cystic fibrosis airways","volume":"186","author":"Vega-Carrascal","year":"2011","journal-title":"J Immunol"},{"key":"2026020402541060100_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI111407","article-title":"Proteins of the cystic fibrosis respiratory tract: fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis","volume":"74","author":"Fick","year":"1984","journal-title":"J Clin Invest"},{"key":"2026020402541060100_bib26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4049\/jimmunol.0902605","article-title":"IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis","volume":"184","author":"Reeves","year":"2010","journal-title":"J Immunol"},{"key":"2026020402541060100_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0954-6111(05)80333-6","article-title":"The effect of neutrophil protenase enzymes on the release of mucus from feline and human airway cultures","volume":"88","author":"Lundgren","year":"1994","journal-title":"Respir Med"},{"key":"2026020402541060100_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1165\/ajrcmb.18.1.2841","article-title":"Neutrophil elastase promotes rapid exocytosis in human airway gland cells by producing cytosolic Ca2+ oscillations","volume":"18","author":"Maizieres","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402541060100_bib29","doi-asserted-by":"crossref","first-page":"L1293","DOI":"10.1152\/ajplung.00140.2004","article-title":"Neutrophil elastase induces mucus cell metaplasia in mouse lung","volume":"287","author":"Voynow","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020402541060100_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1165\/ajrcmb.26.4.4473","article-title":"Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species","volume":"26","author":"Fischer","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402541060100_bib31","first-page":"L835","article-title":"Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells","volume":"276","author":"Voynow","year":"1999","journal-title":"Am J Physiol"},{"key":"2026020402541060100_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1165\/ajrcmb\/4.1.26","article-title":"Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium","volume":"4","author":"Amitani","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402541060100_bib33","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.4049\/jimmunol.178.9.5871","article-title":"Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression","volume":"178","author":"Geraghty","year":"2007","journal-title":"J Immunol"},{"key":"2026020402541060100_bib34","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/423821","article-title":"Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis","volume":"190","author":"Rogan","year":"2004","journal-title":"J Infect Dis"},{"key":"2026020402541060100_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.171.2.931","article-title":"Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins","volume":"171","author":"Taggart","year":"2003","journal-title":"J Immunol"},{"key":"2026020402541060100_bib36","doi-asserted-by":"crossref","first-page":"33345","DOI":"10.1074\/jbc.M103220200","article-title":"Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor","volume":"276","author":"Taggart","year":"2001","journal-title":"J Biol Chem"},{"key":"2026020402541060100_bib37","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.4049\/jimmunol.0901716","article-title":"Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation","volume":"183","author":"Weldon","year":"2009","journal-title":"J Immunol"},{"key":"2026020402541060100_bib38","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.4049\/jimmunol.175.11.7594","article-title":"Viral inhibition of IL-1\u2013 and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells","volume":"175","author":"Carroll","year":"2005","journal-title":"J Immunol"},{"key":"2026020402541060100_bib39","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.1400132","article-title":"Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals","volume":"193","author":"Hurley","year":"2014","journal-title":"J Immunol"},{"key":"2026020402541060100_bib40","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.4049\/jimmunol.150.11.5124","article-title":"Impairment of function in aging neutrophils is associated with apoptosis","volume":"150","author":"Whyte","year":"1993","journal-title":"J Immunol"},{"key":"2026020402541060100_bib41","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.149.9.3059","article-title":"Alpha-1-antichymotrypsin inhibits the NADPH oxidase\u2013enzyme complex in phorbol ester\u2013stimulated neutrophil membranes","volume":"149","author":"Kilpatrick","year":"1992","journal-title":"J Immunol"},{"key":"2026020402541060100_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-5793(92)80156-B","article-title":"Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin","volume":"300","author":"Bucurenci","year":"1992","journal-title":"FEBS Lett"},{"key":"2026020402541060100_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/bjd.13611","article-title":"Alpha-1-antitrypsin deficiency panniculitis presenting with severe anasarca, pulmonary embolus and hypogammaglobulinaemia","volume":"173","author":"Elsensohn","year":"2015","journal-title":"Br J Dermatol"},{"key":"2026020402541060100_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/17476348.2015.1002472","article-title":"The efficacy and safety of inhaled human \u03b1-1 antitrypsin in people with \u03b1-1 antitrypsin deficiency-related emphysema","volume":"9","author":"Franciosi","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"2026020402541060100_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2249.1995.tb03652.x","article-title":"Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)\u2013associated systemic vasculitis","volume":"100","author":"Savige","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2026020402541060100_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int"},{"key":"2026020402541060100_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1165\/ajrcmb.24.6.4147","article-title":"Anti\u2013proteinase 3 antibody activation of neutrophils can be inhibited by \u03b11-antitrypsin","volume":"24","author":"Rooney","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402541060100_bib48","doi-asserted-by":"crossref","first-page":"217ra1","DOI":"10.1126\/scitranslmed.3007116","article-title":"The circulating proteinase inhibitor \u03b1-1 antitrypsin regulates neutrophil degranulation and autoimmunity","volume":"6","author":"Bergin","year":"2014","journal-title":"Sci Transl Med"},{"key":"2026020402541060100_bib49","first-page":"7101","article-title":"Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor","volume":"50","author":"Spriggs","year":"1990","journal-title":"Cancer Res"},{"key":"2026020402541060100_bib50","first-page":"432","article-title":"Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells","volume":"23","author":"Sato","year":"1996","journal-title":"J Rheumatol"},{"key":"2026020402541060100_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1165\/ajrcmb.19.2.3149","article-title":"Inhibition of TNF-\u03b1\u2013induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132","volume":"19","author":"Fiedler","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020402541060100_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1006667703202","article-title":"Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases","volume":"20","author":"Chikazawa","year":"2000","journal-title":"J Clin Immunol"},{"key":"2026020402541060100_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10067-004-1040-2","article-title":"Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates","volume":"24","author":"Caccavo","year":"2005","journal-title":"Clin Rheumatol"},{"key":"2026020402541060100_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4757-9068-9_39","article-title":"Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis","volume":"443","author":"Roozendaal","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"2026020402541060100_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15412550500493220","article-title":"Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira","volume":"3","author":"Stocks","year":"2006","journal-title":"COPD"},{"key":"2026020402541060100_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ppul.20345","article-title":"Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis","volume":"41","author":"Martin","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"2026020402541060100_bib57","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198704233161704","article-title":"Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema","volume":"316","author":"Wewers","year":"1987","journal-title":"N Engl J Med"},{"key":"2026020402541060100_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/TCRM.S51474","article-title":"Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes","volume":"11","author":"Chotirmall","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"2026020402541060100_bib59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.00159408","article-title":"Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency","volume":"33","author":"Dirksen","year":"2009","journal-title":"Eur Respir J"},{"key":"2026020402541060100_bib60","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1164\/ajrccm.160.5.9901055","article-title":"A randomized clinical trial of \u03b1(1)-antitrypsin augmentation therapy","volume":"160","author":"Dirksen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402541060100_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15412550902905961","article-title":"Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis","volume":"6","author":"Chapman","year":"2009","journal-title":"COPD"},{"key":"2026020402541060100_bib62","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"key":"2026020402541060100_bib63","first-page":"687","article-title":"The effects of weekly augmentation therapy in patients with PiZZ \u03b11-antitrypsin deficiency","volume":"7","author":"Schmid","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026020402541060100_bib64","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1164\/rccm.2109013","article-title":"The effect of augmentation therapy on bronchial inflammation in \u03b11-antitrypsin deficiency","volume":"165","author":"Stockley","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402541060100_bib65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jama.1988.03410090091037","article-title":"Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency","volume":"260","author":"Hubbard","year":"1988","journal-title":"JAMA"},{"key":"2026020402541060100_bib66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12931-014-0112-3","article-title":"The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency","volume":"15","author":"Pini","year":"2014","journal-title":"Respir Res"},{"key":"2026020402541060100_bib67","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1582-4934.2008.00608.x","article-title":"Small-molecule peptides inhibit Z alpha1-antitrypsin polymerization","volume":"13","author":"Chang","year":"2009","journal-title":"J Cell Mol Med"},{"key":"2026020402541060100_bib68","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1021\/jm070687z","article-title":"Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates","volume":"50","author":"Mallya","year":"2007","journal-title":"J Med Chem"},{"key":"2026020402541060100_bib69","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/thx.53.12.1018","article-title":"Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis","volume":"53","author":"Hull","year":"1998","journal-title":"Thorax"},{"key":"2026020402541060100_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00365540050164263","article-title":"TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment","volume":"32","author":"Karpati","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"2026020402541060100_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1183\/09031936.00047306","article-title":"alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients","volume":"29","author":"Griese","year":"2007","journal-title":"Eur Respir J"},{"key":"2026020402541060100_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-007-0748-y","article-title":"Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations","volume":"31","author":"Greene","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"2026020402541060100_bib73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1165\/rcmb.2002-0258OC","article-title":"Inhibition of proteinase 3 by \u03b11-antitrypsin in vitro predicts very fast inhibition in vivo","volume":"29","author":"Duranton","year":"2003","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/Supplement_4\/S297\/66667393\/annalsats_13_supplement_4_s297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/Supplement_4\/S297\/66667393\/annalsats_13_supplement_4_s297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:54:39Z","timestamp":1770191679000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/Supplement_4\/S297\/8449176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":73,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2016,8,1]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201509-634kv","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,8]]},"published":{"date-parts":[[2016,8,1]]}}}